Seguir
Esther Bernaldo de Quirós
Esther Bernaldo de Quirós
Investigadora Postdoctoral, Instituto de Investigación Sanitaria Gregorio Marañón (IISGM)
Dirección de correo verificada de iisgm.com
Título
Citado por
Citado por
Año
Imbalance in T-helper 17 cells and targeted therapy in an infant with SAM-like syndrome
A Hernández-Martín, R Kennedy-Batalla, E Cañedo, ...
New England Journal of Medicine 381 (22), 2176-2178, 2019
272019
Basiliximab impairs regulatory T cell (TREG) function and could affect the short-term graft acceptance in children with heart transplantation
J López-Abente, M Martínez-Bonet, E Bernaldo-de-Quirós, M Camino, ...
Scientific reports 11 (1), 1-12, 2021
212021
Immune dysregulation and Th2 polarization are associated with atopic dermatitis in heart‐transplant children: A delicate balance between risk of rejection or atopic symptoms
J López‐Abente, E Bernaldo‐de‐Quirós, M Camino, N Gil, E Panadero, ...
American Journal of Transplantation 19 (5), 1536-1544, 2019
172019
A Novel GMP Protocol to Produce High-Quality Treg Cells From the Pediatric Thymic Tissue to Be Employed as Cellular Therapy.
E Bernaldo-de-Quirós, B Cózar, R López-Esteban, M Clemente, ...
Frontiers in immunology 13, 893576-893576, 2022
82022
Ectopic FOXP3 Expression in Combination with TGF-β1 and IL-2 Stimulation Generates Limited Suppressive Function in Human Primary Activated Thymocytes Ex Vivo
J Gallego-Valle, S Gil-Manso, A Pita, E Bernaldo-de-Quirós, ...
Biomedicines 9 (5), 461, 2021
72021
Multidimensional analysis of immune cells from COVID-19 patients identified cell subsets associated with the severity at hospital admission
S Gil-Manso, D Herrero-Quevedo, D Carbonell, M Martínez-Bonet, ...
Plos Pathogens 19 (6), e1011432, 2023
52023
The presence of a marked imbalance between regulatory T cells and effector T cells reveals that tolerance mechanisms could be compromised in heart transplant children
E Bernaldo-de-Quirós, J López-Abente, M Camino, N Gil, E Panadero, ...
Transplantation direct 7 (5), 2021
52021
A New Generation of Cell Therapies Employing Regulatory T Cells (Treg) to Induce Immune Tolerance in Pediatric Transplantation
E Bernaldo-de-Quirós, M Pion, M Martínez-Bonet, R Correa-Rocha
Frontiers in Pediatrics 10, 2022
32022
" First-In-Human" Clinical Trial Employing Adoptive Transfer of Autologous Thymus-Derived Treg Cells (thyTreg) to Prevent Graft Rejection in Heart-Transplanted Children
E Bernaldo de Quiros, M Camino, N Gil, E Panadero, C Medrano, ...
Transplantation 102, S205-S205, 2018
32018
213.2: Preliminary results of the first clinical trial to prevent graft rejection in heart transplant children employing a cellular therapy with autologous treg obtained from …
E Bernaldo-de-Quirós, M Camino, JM Gil-Jaurena, N Gil, ...
Transplantation 106 (9S), S28, 2022
12022
Thymus-derived Treg infusion to prevent graft rejection in heart-transplanted children: initial exploration of a new therapeutic arsenal to boost immune tolerance
EB de Quirós, VA Pérez, M Clemente, JM Gil-Jaurena, MT González, ...
Transplantation 101 (5S-3), S36, 2017
12017
First-in-human therapy with Treg produced from thymic tissue (thyTreg) in a heart transplant infant
E Bernaldo-de-Quirós, M Camino, M Martínez-Bonet, JM Gil-Jaurena, ...
Journal of Experimental Medicine 220 (12), e20231045, 2023
2023
AVIDIN-BASED CHIMERIC ANTIGEN RECEPTOR SPECIFICALLY ENHANCES THYMUS-DERIVED REGULATORY T CELLS ACTIVATION AND FUNCTIONALITY
J Gallego Valle, V Perez Fernandez, M Martinez-Bonet, R Lopez, ...
CYTOTHERAPY 24 (5), S128-S129, 2022
2022
A NOVEL GMP PROTOCOL USING THE HUMAN THYMUS AS A NEW SOURCE OF REGULATORY T CELLS (THYTREG) TO BE EMPLOYED AS AN AUTOLOGOUS CELLULAR THERAPY IN HEART TRANSPLANTED CHILDREN
E Bernaldo de Quiros, M Camino, J Gil-Jaurena, N Gil, ...
CYTOTHERAPY 24 (5), S38-S39, 2022
2022
Primer ensayo clínico para prevenir el rechazo en niños trasplantados de corazón mediante una terapia celular con Treg autólogas obtenidas a partir de tejido tímico (thyTreg)
E Bernaldo de Quirós Plaza
2022
Primer ensayo clínico para prevenir el rechazo en niños trasplantados de corazón mediante una terapia celular con Treg autólogas obtenidas a partir de tejido tímico (thyTreg)
EB de Quirós Plaza
Universidad Autónoma de Madrid, 2022
2022
Avidin-based universal CAR regulatory T cells (UniCAR-Tregs): a versatile approach for future immunotherapy
J Gallego-Valle, S Gil-Manso, A Pita, E Bernaldo-de-Quiros, ...
EUROPEAN JOURNAL OF IMMUNOLOGY 51, 116-116, 2021
2021
Ectopic FOXP3 Expression in Combination with TGF-β1 and IL-2 Stimulation Generates Limited Suppressive Function in Human Primary Activated Thymocytes Ex Vivo. Biomedicines 2021 …
J Gallego-Valle, S Gil-Manso, A Pita, E Bernaldo-de-Quirós, ...
s Note: MDPI stays neu-tral with regard to jurisdictional claims in …, 2021
2021
“FIRST-IN-HUMAN” CLINICAL TRIAL EMPLOYING ADOPTIVE TRANSFER OF AUTOLOGOUS THYMUS-DERIVED TREG CELLS (THYTREG) TO PREVENT GRAFT REJECTION IN HEART-TRANSPLANTED CHILDREN
E Bernaldo-de-Quiros, M Camino, JM Gil-Jaurena, E Fernández-Santos, ...
Transplantation 104 (S3), S22, 2020
2020
Papel de las células T reguladoras en la alergia a proteínas de leche de vaca no mediada por IGE en la infancia
J Pérez Moreno
Universidad Complutense de Madrid, 2019
2019
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20